New patent for Boehringer Ingelheim drug TRADJENTABy DrugPatentWatch – Make Better Decisions / March 27, 2024 Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from three suppliers. There are eight patents…Source